Objective-To determine if treatment of BV decrease the incidence of sexually transmitted diseases.Study Design-Women with asymptomatic BV were studied prospectively to determine the effect of treatment of BV for the prevention of STD. Women were randomized to observation or treatment and prophylaxis with intravaginal metronidazole gel. Women were screened monthly for STDs.Results-Women randomized to metronidazole gel had a significantly longer time to development of STD compared to women in the observation group (p=0.02). The 6-month STD rate was 1.58/ person-year (95% CI 1.29, 1.87) for women in the metronidazole gel group versus 2.29/person-year (95% CI 1.95, 2.63) for women in the observational group. The difference in STD rates was driven by a significant difference in the number of chlamydial infections (0.013).Conclusion-Treatment and twice-weekly prophylactic use of intravaginal metronidazole gel resulted in significantly fewer cases of chlamydia.